Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.74B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$760M |
| 3 |
Alibaba
BABA
|
+$429M |
| 4 |
Stellantis
STLA
|
+$372M |
| 5 |
CERN
Cerner Corp
CERN
|
+$304M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.85B |
| 2 |
Microsoft
MSFT
|
+$1.75B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.22B |
| 4 |
Amazon
AMZN
|
+$1.04B |
| 5 |
iShares US Real Estate ETF
IYR
|
+$924M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.06% |
| 2 | Financials | 14.44% |
| 3 | Healthcare | 10.25% |
| 4 | Consumer Discretionary | 9.7% |
| 5 | Communication Services | 8.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
Newmark Group
NMRK
$2.66B
| $448K | ﹤0.01% |
28,199
-158,800
| -85% | -$2.59M |
|
2877
Vital Farms
VITL
$545M
| $448K | ﹤0.01% |
+36,284
| New | +$545K |
|
2878
Lincoln Electric
LECO
$14.2B
| $447K | ﹤0.01% |
3,248
-9,881
| -75% | -$1.29M |
|
|
LL
2879
DELISTED
LL Flooring Holdings, Inc.
LL
| $447K | ﹤0.01% |
31,908
-24,537
| -43% | -$375K |
|
2880
TScan Therapeutics
TCRX
$48.6M
| $445K | ﹤0.01% |
+158,944
| New | +$687K |
|
2881
Verra Mobility
VRRM
$804M
| $445K | ﹤0.01% |
27,386
-158,327
| -85% | -$2.55M |
|
2882
Golar LNG
GLNG
$5B
| $444K | ﹤0.01% |
17,904
-669,327
| -97% | -$11M |
|
|
CCV
2883
DELISTED
Churchill Capital Corp V
CCV
| $444K | ﹤0.01% |
+45,127
| New | +$442K |
|
2884
Radware
RDWR
$1.1B
| $443K | ﹤0.01% |
13,889
-860
| -6% | -$28.6K |
|
2885
Surgery Partners
SGRY
$2.01B
| $443K | ﹤0.01% |
8,042
-33,213
| -81% | -$1.64M |
|
|
MAGN
2886
Magnera Corp
MAGN
$472M
| $443K | ﹤0.01% |
+2,746
| New | +$544K |
|
2887
Mercantile Bank Corp
MBWM
$1.04B
| $441K | ﹤0.01% |
12,463
-6,793
| -35% | -$254K |
|
2888
Sutro Biopharma
STRO
$401M
| $441K | ﹤0.01% |
5,359
-30,080
| -85% | -$2.86M |
|
2889
Frontier Group Holdings
ULCC
$1.55B
| $441K | ﹤0.01% |
38,937
-3,327
| -8% | -$41.8K |
|
|
SOVO
2890
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $441K | ﹤0.01% |
+31,103
| New | +$416K |
|
2891
Columbia Sportswear
COLM
$3.04B
| $439K | ﹤0.01% |
4,838
-4,754
| -50% | -$440K |
|
2892
Brunswick
BC
$5.13B
| $438K | ﹤0.01% |
5,422
-32,614
| -86% | -$3.01M |
|
2893
Otter Tail
OTTR
$3.71B
| $437K | ﹤0.01% |
6,987
-42,965
| -86% | -$2.7M |
|
|
NKLA
2894
DELISTED
Nikola Corporation Common Stock
NKLA
| $435K | ﹤0.01% |
+1,352
| New | +$345K |
|
2895
Black Stone Minerals
BSM
$3.18B
| $434K | ﹤0.01% |
32,236
+3,500
| +12% | +$41.7K |
|
|
AONC
2896
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
| $433K | ﹤0.01% |
+44,321
| New | +$431K |
|
|
SUMO
2897
DELISTED
Sumo Logic, Inc. Common Stock
SUMO
| $433K | ﹤0.01% |
+37,068
| New | +$430K |
|
2898
BridgeBio Pharma
BBIO
$15.7B
| $432K | ﹤0.01% |
42,586
-151,488
| -78% | -$1.55M |
|
|
CHUY
2899
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $432K | ﹤0.01% |
15,987
-9,995
| -38% | -$278K |
|
2900
CNA Financial
CNA
$14.2B
| $430K | ﹤0.01% |
8,851
-1,865
| -17% | -$86.8K |
|
Similar funds
Barclays's Q1 2022 Portfolio in Review
As of Q1 2022, Barclays held 5,876 positions worth $128B, down 52% from $268B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $131B in Q1 2022, closing 907 positions and reducing 2,310 holdings. Its most notable exit was Nuance Communications, Inc., an estimated $631M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Barclays opened a new position in Stellantis worth $331M.
- Barclays's largest Q1 2022 buy was Stellantis: 20,333,315 shares worth $331M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.74B increase.
- Barclays's biggest Q1 2022 reduction was Apple, cutting an estimated $1.85B.
- Barclays fully exited Nuance Communications, Inc. in Q1 2022, selling an estimated $631M.
- Barclays's ten largest holdings make up 22% of its $128B portfolio in Q1 2022.
- Barclays opened 1,592 new positions and closed 907 in Q1 2022.
- Barclays's portfolio value fell 52% quarter-over-quarter to $128B.
Based on Barclays's 13F filing for Q1 2022, filed 16 May 2022.